gene therapy

AstraZeneca

AZ forges surprise R&D deal with virus gene therapy biotech

MedImmune, the R&D arm of AstraZeneca has teamed up with California based 4DMT, a next-generation virus-based gene therapy research house developing a treatment for chronic lung disease

Partner Content

Partner Content

An experimental gene therapy for DMD shows positive results

Cell & Gene Therapy 2018

Partner Content

Partner Content

Exclusive Speaker Interview for SMI’s Inaugural Cell & G...

Speaker Interview for Cell & Gene Therapy 2018

Partner Content

Partner Content

From Manufacturing to Patient Access: SMi’s Cell & Gene ...

Cell & Gene Therapy

News

Spark/Pfizer eye phase 3 trial of haemophilia B gene therapy

Spark Therapeutics has already revolutionised treatment of a rare hereditary eye disease with a gene therapy, but could it be about to do the same with haemophilia B?

Partner Content